HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 08-APR-13 4K26 TITLE 4,4-DIOXO-5,6-DIHYDRO-[1,4,3]OXATHIAZINES, A NOVEL CLASS OF 11 -HSD1 TITLE 2 INHIBITORS FOR THE TREATMENT OF DIABETES COMPND MOL_ID: 1; COMPND 2 MOLECULE: CORTICOSTEROID 11-BETA-DEHYDROGENASE ISOZYME 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: MURINE 11-BETA-HSD_24-292; COMPND 5 SYNONYM: 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1, 11-DH, 11-BETA-HSD1, COMPND 6 11BETA-HSD1A; COMPND 7 EC: 1.1.1.146; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: HSD11B1, HSD11; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS OXIDOREDUCTASE, ALPHA AND BETA PROTEINS, NAD(P)-BINDING ROSSMAN-FOLD, KEYWDS 2 SHORT CHAIN DEHYDROGENASE, OXIDOREDUCTASE-OXIDOREDUCTASE INHIBITOR KEYWDS 3 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR P.LOENZE,S.SCHIMANSKI-BREVES,C.VONDERHEYDEN,C.K.ENGEL REVDAT 1 09-APR-14 4K26 0 JRNL AUTH T.BOHME,C.K.ENGEL,G.FARJOT,S.GUSSREGEN,T.HAACK,G.TSCHANK, JRNL AUTH 2 K.RITTER JRNL TITL 1,1-DIOXO-5,6-DIHYDRO-[4,1,2]OXATHIAZINES, A NOVEL CLASS OF JRNL TITL 2 11-HSD1 INHIBITORS FOR THE TREATMENT OF DIABETES. JRNL REF BIOORG.MED.CHEM.LETT. V. 23 4685 2013 JRNL REFN ISSN 0960-894X JRNL PMID 23845218 JRNL DOI 10.1016/J.BMCL.2013.05.102 REMARK 2 REMARK 2 RESOLUTION. 2.21 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.21 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.82 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 32890 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.168 REMARK 3 R VALUE (WORKING SET) : 0.166 REMARK 3 FREE R VALUE : 0.208 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.190 REMARK 3 FREE R VALUE TEST SET COUNT : 1706 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 16 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.21 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.28 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.95 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2991 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2014 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2843 REMARK 3 BIN R VALUE (WORKING SET) : 0.1983 REMARK 3 BIN FREE R VALUE : 0.2625 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.95 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 148 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4078 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 149 REMARK 3 SOLVENT ATOMS : 253 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.85 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.56 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.37180 REMARK 3 B22 (A**2) : 0.15150 REMARK 3 B33 (A**2) : 0.22030 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.217 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.946 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.918 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4318 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5835 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1577 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 83 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 648 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4318 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 585 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5449 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.17 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.35 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.25 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4K26 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-APR-13. REMARK 100 THE RCSB ID CODE IS RCSB078796. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-DEC-06 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32949 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.210 REMARK 200 RESOLUTION RANGE LOW (A) : 95.820 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.12700 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.21 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.40 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.43500 REMARK 200 FOR SHELL : 4.650 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: BUSTER REMARK 200 STARTING MODEL: PDB ENTRY 1Y5R REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.59 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.65 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HEPES 100MM PH 7.5, (NH4)2SO4 1.7M, 1 REMARK 280 MM NADP, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 35.27850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 35.27850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 66.93200 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 68.66650 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 66.93200 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 68.66650 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 35.27850 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 66.93200 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 68.66650 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 35.27850 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 66.93200 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 68.66650 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8340 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21030 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -102.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 17 REMARK 465 HIS A 18 REMARK 465 HIS A 19 REMARK 465 HIS A 20 REMARK 465 HIS A 21 REMARK 465 HIS A 22 REMARK 465 HIS A 23 REMARK 465 ASN A 24 REMARK 465 VAL A 290 REMARK 465 SER A 291 REMARK 465 ASN A 292 REMARK 465 MET B 17 REMARK 465 HIS B 18 REMARK 465 HIS B 19 REMARK 465 HIS B 20 REMARK 465 HIS B 21 REMARK 465 HIS B 22 REMARK 465 HIS B 23 REMARK 465 ASN B 24 REMARK 465 VAL B 290 REMARK 465 SER B 291 REMARK 465 ASN B 292 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 65 -179.35 179.33 REMARK 500 MET A 179 0.99 81.77 REMARK 500 ASP A 219 38.56 -71.63 REMARK 500 ILE A 230 -52.51 -122.89 REMARK 500 ALA B 65 172.14 178.23 REMARK 500 HIS B 130 14.05 -158.68 REMARK 500 ALA B 172 0.30 -68.71 REMARK 500 MET B 179 9.91 83.64 REMARK 500 ILE B 180 34.59 -143.08 REMARK 500 ASP B 219 49.52 -71.86 REMARK 500 ASN B 270 70.47 55.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 LEU A 155 23.3 L L OUTSIDE RANGE REMARK 500 GLU B 239 23.1 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 486 DISTANCE = 5.32 ANGSTROMS REMARK 525 HOH A 504 DISTANCE = 6.83 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SFF A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SFF B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP B 303 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4K1L RELATED DB: PDB REMARK 900 ENTRY 4K1L SHOWS THE SAME INHIBITOR IN HUMAN 11-HSD-1 DBREF 4K26 A 24 292 UNP P50172 DHI1_MOUSE 24 292 DBREF 4K26 B 24 292 UNP P50172 DHI1_MOUSE 24 292 SEQADV 4K26 MET A 17 UNP P50172 EXPRESSION TAG SEQADV 4K26 HIS A 18 UNP P50172 EXPRESSION TAG SEQADV 4K26 HIS A 19 UNP P50172 EXPRESSION TAG SEQADV 4K26 HIS A 20 UNP P50172 EXPRESSION TAG SEQADV 4K26 HIS A 21 UNP P50172 EXPRESSION TAG SEQADV 4K26 HIS A 22 UNP P50172 EXPRESSION TAG SEQADV 4K26 HIS A 23 UNP P50172 EXPRESSION TAG SEQADV 4K26 MET B 17 UNP P50172 EXPRESSION TAG SEQADV 4K26 HIS B 18 UNP P50172 EXPRESSION TAG SEQADV 4K26 HIS B 19 UNP P50172 EXPRESSION TAG SEQADV 4K26 HIS B 20 UNP P50172 EXPRESSION TAG SEQADV 4K26 HIS B 21 UNP P50172 EXPRESSION TAG SEQADV 4K26 HIS B 22 UNP P50172 EXPRESSION TAG SEQADV 4K26 HIS B 23 UNP P50172 EXPRESSION TAG SEQRES 1 A 276 MET HIS HIS HIS HIS HIS HIS ASN GLU GLU PHE ARG PRO SEQRES 2 A 276 GLU MET LEU GLN GLY LYS LYS VAL ILE VAL THR GLY ALA SEQRES 3 A 276 SER LYS GLY ILE GLY ARG GLU MET ALA TYR HIS LEU SER SEQRES 4 A 276 LYS MET GLY ALA HIS VAL VAL LEU THR ALA ARG SER GLU SEQRES 5 A 276 GLU GLY LEU GLN LYS VAL VAL SER ARG CYS LEU GLU LEU SEQRES 6 A 276 GLY ALA ALA SER ALA HIS TYR ILE ALA GLY THR MET GLU SEQRES 7 A 276 ASP MET THR PHE ALA GLU GLN PHE ILE VAL LYS ALA GLY SEQRES 8 A 276 LYS LEU MET GLY GLY LEU ASP MET LEU ILE LEU ASN HIS SEQRES 9 A 276 ILE THR GLN THR SER LEU SER LEU PHE HIS ASP ASP ILE SEQRES 10 A 276 HIS SER VAL ARG ARG VAL MET GLU VAL ASN PHE LEU SER SEQRES 11 A 276 TYR VAL VAL MET SER THR ALA ALA LEU PRO MET LEU LYS SEQRES 12 A 276 GLN SER ASN GLY SER ILE ALA VAL ILE SER SER LEU ALA SEQRES 13 A 276 GLY LYS MET THR GLN PRO MET ILE ALA PRO TYR SER ALA SEQRES 14 A 276 SER LYS PHE ALA LEU ASP GLY PHE PHE SER THR ILE ARG SEQRES 15 A 276 THR GLU LEU TYR ILE THR LYS VAL ASN VAL SER ILE THR SEQRES 16 A 276 LEU CYS VAL LEU GLY LEU ILE ASP THR GLU THR ALA MET SEQRES 17 A 276 LYS GLU ILE SER GLY ILE ILE ASN ALA GLN ALA SER PRO SEQRES 18 A 276 LYS GLU GLU CYS ALA LEU GLU ILE ILE LYS GLY THR ALA SEQRES 19 A 276 LEU ARG LYS SER GLU VAL TYR TYR ASP LYS SER PRO LEU SEQRES 20 A 276 THR PRO ILE LEU LEU GLY ASN PRO GLY ARG LYS ILE MET SEQRES 21 A 276 GLU PHE PHE SER LEU ARG TYR TYR ASN LYS ASP MET PHE SEQRES 22 A 276 VAL SER ASN SEQRES 1 B 276 MET HIS HIS HIS HIS HIS HIS ASN GLU GLU PHE ARG PRO SEQRES 2 B 276 GLU MET LEU GLN GLY LYS LYS VAL ILE VAL THR GLY ALA SEQRES 3 B 276 SER LYS GLY ILE GLY ARG GLU MET ALA TYR HIS LEU SER SEQRES 4 B 276 LYS MET GLY ALA HIS VAL VAL LEU THR ALA ARG SER GLU SEQRES 5 B 276 GLU GLY LEU GLN LYS VAL VAL SER ARG CYS LEU GLU LEU SEQRES 6 B 276 GLY ALA ALA SER ALA HIS TYR ILE ALA GLY THR MET GLU SEQRES 7 B 276 ASP MET THR PHE ALA GLU GLN PHE ILE VAL LYS ALA GLY SEQRES 8 B 276 LYS LEU MET GLY GLY LEU ASP MET LEU ILE LEU ASN HIS SEQRES 9 B 276 ILE THR GLN THR SER LEU SER LEU PHE HIS ASP ASP ILE SEQRES 10 B 276 HIS SER VAL ARG ARG VAL MET GLU VAL ASN PHE LEU SER SEQRES 11 B 276 TYR VAL VAL MET SER THR ALA ALA LEU PRO MET LEU LYS SEQRES 12 B 276 GLN SER ASN GLY SER ILE ALA VAL ILE SER SER LEU ALA SEQRES 13 B 276 GLY LYS MET THR GLN PRO MET ILE ALA PRO TYR SER ALA SEQRES 14 B 276 SER LYS PHE ALA LEU ASP GLY PHE PHE SER THR ILE ARG SEQRES 15 B 276 THR GLU LEU TYR ILE THR LYS VAL ASN VAL SER ILE THR SEQRES 16 B 276 LEU CYS VAL LEU GLY LEU ILE ASP THR GLU THR ALA MET SEQRES 17 B 276 LYS GLU ILE SER GLY ILE ILE ASN ALA GLN ALA SER PRO SEQRES 18 B 276 LYS GLU GLU CYS ALA LEU GLU ILE ILE LYS GLY THR ALA SEQRES 19 B 276 LEU ARG LYS SER GLU VAL TYR TYR ASP LYS SER PRO LEU SEQRES 20 B 276 THR PRO ILE LEU LEU GLY ASN PRO GLY ARG LYS ILE MET SEQRES 21 B 276 GLU PHE PHE SER LEU ARG TYR TYR ASN LYS ASP MET PHE SEQRES 22 B 276 VAL SER ASN HET SFF A 301 19 HET SO4 A 302 5 HET SO4 A 303 5 HET NDP A 304 48 HET SFF B 301 19 HET SO4 B 302 5 HET NDP B 303 48 HETNAM SFF (4AS,8AR)-N-CYCLOHEXYL-4A,5,6,7,8,8A-HEXAHYDRO-4,1,2- HETNAM 2 SFF BENZOXATHIAZIN-3-AMINE 1,1-DIOXIDE HETNAM SO4 SULFATE ION HETNAM NDP NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM 2 NDP PHOSPHATE FORMUL 3 SFF 2(C13 H22 N2 O3 S) FORMUL 4 SO4 3(O4 S 2-) FORMUL 6 NDP 2(C21 H30 N7 O17 P3) FORMUL 10 HOH *253(H2 O) HELIX 1 1 ARG A 28 GLN A 33 5 6 HELIX 2 2 LYS A 44 MET A 57 1 14 HELIX 3 3 SER A 67 GLY A 82 1 16 HELIX 4 4 ASP A 95 GLY A 111 1 17 HELIX 5 5 ASP A 132 PHE A 144 1 13 HELIX 6 6 PHE A 144 ASN A 162 1 19 HELIX 7 7 ALA A 172 LYS A 174 5 3 HELIX 8 8 ILE A 180 THR A 204 1 25 HELIX 9 9 THR A 220 SER A 228 1 9 HELIX 10 10 PRO A 237 LEU A 251 1 15 HELIX 11 11 LEU A 263 GLY A 269 1 7 HELIX 12 12 ASN A 270 LEU A 281 1 12 HELIX 13 13 ARG A 282 TYR A 284 5 3 HELIX 14 14 ASN A 285 PHE A 289 5 5 HELIX 15 15 ARG B 28 GLN B 33 5 6 HELIX 16 16 LYS B 44 MET B 57 1 14 HELIX 17 17 SER B 67 LEU B 81 1 15 HELIX 18 18 ASP B 95 GLY B 111 1 17 HELIX 19 19 ASP B 132 PHE B 144 1 13 HELIX 20 20 PHE B 144 ASN B 162 1 19 HELIX 21 21 ALA B 172 LYS B 174 5 3 HELIX 22 22 ILE B 180 THR B 204 1 25 HELIX 23 23 THR B 220 ILE B 227 1 8 HELIX 24 24 PRO B 237 LEU B 251 1 15 HELIX 25 25 PRO B 262 GLY B 269 1 8 HELIX 26 26 ASN B 270 LEU B 281 1 12 HELIX 27 27 ARG B 282 TYR B 284 5 3 HELIX 28 28 ASN B 285 PHE B 289 5 5 SHEET 1 A 7 SER A 85 TYR A 88 0 SHEET 2 A 7 HIS A 60 LEU A 63 1 N LEU A 63 O HIS A 87 SHEET 3 A 7 LYS A 36 VAL A 39 1 N VAL A 37 O HIS A 60 SHEET 4 A 7 MET A 115 LEU A 118 1 O ILE A 117 N ILE A 38 SHEET 5 A 7 SER A 164 SER A 170 1 O ALA A 166 N LEU A 116 SHEET 6 A 7 SER A 209 LEU A 215 1 O THR A 211 N VAL A 167 SHEET 7 A 7 GLU A 255 TYR A 258 1 O VAL A 256 N VAL A 214 SHEET 1 B 7 SER B 85 TYR B 88 0 SHEET 2 B 7 HIS B 60 LEU B 63 1 N LEU B 63 O HIS B 87 SHEET 3 B 7 LYS B 36 VAL B 39 1 N VAL B 37 O HIS B 60 SHEET 4 B 7 MET B 115 LEU B 118 1 O ILE B 117 N ILE B 38 SHEET 5 B 7 SER B 164 SER B 170 1 O ALA B 166 N LEU B 118 SHEET 6 B 7 SER B 209 LEU B 215 1 O THR B 211 N ILE B 165 SHEET 7 B 7 GLU B 255 TYR B 258 1 O VAL B 256 N VAL B 214 SITE 1 AC1 11 SER A 170 LEU A 171 ALA A 172 GLN A 177 SITE 2 AC1 11 TYR A 183 LEU A 215 GLY A 216 LEU A 217 SITE 3 AC1 11 ILE A 227 NDP A 304 HOH A 499 SITE 1 AC2 8 GLY A 45 ARG A 48 THR A 220 GLU A 221 SITE 2 AC2 8 LYS A 238 HOH A 406 HOH A 434 HOH A 519 SITE 1 AC3 2 ARG A 48 HOH A 517 SITE 1 AC4 30 GLY A 41 SER A 43 LYS A 44 GLY A 45 SITE 2 AC4 30 ILE A 46 ALA A 65 ARG A 66 SER A 67 SITE 3 AC4 30 THR A 92 MET A 93 ASN A 119 ILE A 121 SITE 4 AC4 30 ILE A 168 SER A 169 SER A 170 TYR A 183 SITE 5 AC4 30 LYS A 187 LEU A 215 GLY A 216 LEU A 217 SITE 6 AC4 30 ILE A 218 THR A 220 THR A 222 ALA A 223 SITE 7 AC4 30 SFF A 301 HOH A 407 HOH A 428 HOH A 434 SITE 8 AC4 30 HOH A 468 LYS B 225 SITE 1 AC5 12 THR B 124 SER B 170 LEU B 171 ALA B 172 SITE 2 AC5 12 GLN B 177 ILE B 180 TYR B 183 LEU B 215 SITE 3 AC5 12 GLY B 216 LEU B 217 NDP B 303 HOH B 501 SITE 1 AC6 6 LYS A 225 ARG B 66 THR B 122 GLN B 123 SITE 2 AC6 6 ARG B 138 NDP B 303 SITE 1 AC7 29 GLY B 41 SER B 43 LYS B 44 GLY B 45 SITE 2 AC7 29 ILE B 46 ALA B 65 ARG B 66 SER B 67 SITE 3 AC7 29 THR B 92 MET B 93 ASN B 119 ILE B 121 SITE 4 AC7 29 ILE B 168 SER B 169 SER B 170 TYR B 183 SITE 5 AC7 29 LYS B 187 LEU B 215 GLY B 216 LEU B 217 SITE 6 AC7 29 ILE B 218 THR B 220 THR B 222 ALA B 223 SITE 7 AC7 29 SFF B 301 SO4 B 302 HOH B 408 HOH B 409 SITE 8 AC7 29 HOH B 416 CRYST1 133.864 137.333 70.557 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007470 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007282 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014173 0.00000 MASTER 355 0 7 28 14 0 27 6 0 0 0 44 END